Besides the tumor related symptoms (irritable cough, chest distress, and hemoptysis), NSCLC downregulates the CD4/CD8 ratio in patients' peripheral blood and weakens the immune system. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.